Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)

We investigated the ability of NAC to inhibit in vitro LDL oxidation, and the effects of the timing of NAC addition, repeated additions of NAC, and the presence of preoxidized LDL, on the oxidation reaction. NAC inhibited in vitro LDL oxidation induced by copper sulfate, 2,2′-azobis(2-amidinopropane...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 1998-06, Vol.138 (2), p.319-327
Hauptverfasser: Rattan, Anil K., Arad, Yadon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 327
container_issue 2
container_start_page 319
container_title Atherosclerosis
container_volume 138
creator Rattan, Anil K.
Arad, Yadon
description We investigated the ability of NAC to inhibit in vitro LDL oxidation, and the effects of the timing of NAC addition, repeated additions of NAC, and the presence of preoxidized LDL, on the oxidation reaction. NAC inhibited in vitro LDL oxidation induced by copper sulfate, 2,2′-azobis(2-amidinopropane) dihydrochloride, and UV light, and protected LDL against depletion of antioxidant vitamins. Glutathione was similarly effective against copper-mediated LDL oxidation. NAC's effectiveness was inversely related to the timing of its addition. Sequential NAC additions prolonged the lag phase more effectively than initial addition of the same total dose. NAC reduced CD formation during the oxidation of native LDL by oxidized LDL. NAC's effectiveness as an inhibitor of in vitro LDL oxidation is dependent on the temporal sequence of the oxidation reaction, sequential additions, and the presence of previously oxidized LDL.
doi_str_mv 10.1016/S0021-9150(98)00041-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80048554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915098000410</els_id><sourcerecordid>80048554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-1d6ca38e9e7b6f84011fdbc7840079cdcf68a0fa2e9a44d13d0ab5a0ad2e2d3a3</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qFWyhPwHJB1TBIcVOnMQ-VWihH9IKDtBrrYk9EYbE2dpe1P33eD-0V0623nlmxn4IOePsG2e8uXpgrOSF4jW7UPKSMSZ4wT6QGZetKriQ4iOZHZBj8jnG5w3UcnlEjlSjWM5n5O8jjsspwEDBW_riPCZnqMWEYXQefIp06ml6Qur8k-tccpPfJIubBZ3-OwvboFvTuwIMpvVg1jFhHkMv7q7nl6fkUw9DxC_784T8-XH7OP9VLO5__p5fLwoj6joV3DYGKokK267ppWCc97Yzbb6xVhlr-kYC66FEBUJYXlkGXQ0MbImlraA6IV93c5dh-rfCmPToosFhAI_TKmqZfy7rWmSw3oEmTDEG7PUyuBHCWnOmN1711qveSNNK6q1XzXLf2X7BqhvRHrr2InP9fF-HaGDoA3jj4gErq7IUlczY9x2GWcarw6CjcegNWhfQJG0n985D3gC5mJR4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80048554</pqid></control><display><type>article</type><title>Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rattan, Anil K. ; Arad, Yadon</creator><creatorcontrib>Rattan, Anil K. ; Arad, Yadon</creatorcontrib><description>We investigated the ability of NAC to inhibit in vitro LDL oxidation, and the effects of the timing of NAC addition, repeated additions of NAC, and the presence of preoxidized LDL, on the oxidation reaction. NAC inhibited in vitro LDL oxidation induced by copper sulfate, 2,2′-azobis(2-amidinopropane) dihydrochloride, and UV light, and protected LDL against depletion of antioxidant vitamins. Glutathione was similarly effective against copper-mediated LDL oxidation. NAC's effectiveness was inversely related to the timing of its addition. Sequential NAC additions prolonged the lag phase more effectively than initial addition of the same total dose. NAC reduced CD formation during the oxidation of native LDL by oxidized LDL. NAC's effectiveness as an inhibitor of in vitro LDL oxidation is dependent on the temporal sequence of the oxidation reaction, sequential additions, and the presence of previously oxidized LDL.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/S0021-9150(98)00041-0</identifier><identifier>PMID: 9690915</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>Acetylcysteine - metabolism ; Acetylcysteine - pharmacology ; Atherosclerosis ; Biological and medical sciences ; Free Radical Scavengers - metabolism ; Free Radical Scavengers - pharmacology ; Humans ; Kinetics ; LDL ; Lipid Peroxidation - drug effects ; Lipoproteins, LDL - metabolism ; Medical sciences ; Oxidation ; Oxidation-Reduction ; Pharmacology. Drug treatments ; Respiratory system</subject><ispartof>Atherosclerosis, 1998-06, Vol.138 (2), p.319-327</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-1d6ca38e9e7b6f84011fdbc7840079cdcf68a0fa2e9a44d13d0ab5a0ad2e2d3a3</citedby><cites>FETCH-LOGICAL-c455t-1d6ca38e9e7b6f84011fdbc7840079cdcf68a0fa2e9a44d13d0ab5a0ad2e2d3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915098000410$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2322438$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9690915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rattan, Anil K.</creatorcontrib><creatorcontrib>Arad, Yadon</creatorcontrib><title>Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>We investigated the ability of NAC to inhibit in vitro LDL oxidation, and the effects of the timing of NAC addition, repeated additions of NAC, and the presence of preoxidized LDL, on the oxidation reaction. NAC inhibited in vitro LDL oxidation induced by copper sulfate, 2,2′-azobis(2-amidinopropane) dihydrochloride, and UV light, and protected LDL against depletion of antioxidant vitamins. Glutathione was similarly effective against copper-mediated LDL oxidation. NAC's effectiveness was inversely related to the timing of its addition. Sequential NAC additions prolonged the lag phase more effectively than initial addition of the same total dose. NAC reduced CD formation during the oxidation of native LDL by oxidized LDL. NAC's effectiveness as an inhibitor of in vitro LDL oxidation is dependent on the temporal sequence of the oxidation reaction, sequential additions, and the presence of previously oxidized LDL.</description><subject>Acetylcysteine - metabolism</subject><subject>Acetylcysteine - pharmacology</subject><subject>Atherosclerosis</subject><subject>Biological and medical sciences</subject><subject>Free Radical Scavengers - metabolism</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>LDL</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Medical sciences</subject><subject>Oxidation</subject><subject>Oxidation-Reduction</subject><subject>Pharmacology. Drug treatments</subject><subject>Respiratory system</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhq2qFWyhPwHJB1TBIcVOnMQ-VWihH9IKDtBrrYk9EYbE2dpe1P33eD-0V0623nlmxn4IOePsG2e8uXpgrOSF4jW7UPKSMSZ4wT6QGZetKriQ4iOZHZBj8jnG5w3UcnlEjlSjWM5n5O8jjsspwEDBW_riPCZnqMWEYXQefIp06ml6Qur8k-tccpPfJIubBZ3-OwvboFvTuwIMpvVg1jFhHkMv7q7nl6fkUw9DxC_784T8-XH7OP9VLO5__p5fLwoj6joV3DYGKokK267ppWCc97Yzbb6xVhlr-kYC66FEBUJYXlkGXQ0MbImlraA6IV93c5dh-rfCmPToosFhAI_TKmqZfy7rWmSw3oEmTDEG7PUyuBHCWnOmN1711qveSNNK6q1XzXLf2X7BqhvRHrr2InP9fF-HaGDoA3jj4gErq7IUlczY9x2GWcarw6CjcegNWhfQJG0n985D3gC5mJR4</recordid><startdate>19980601</startdate><enddate>19980601</enddate><creator>Rattan, Anil K.</creator><creator>Arad, Yadon</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980601</creationdate><title>Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)</title><author>Rattan, Anil K. ; Arad, Yadon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-1d6ca38e9e7b6f84011fdbc7840079cdcf68a0fa2e9a44d13d0ab5a0ad2e2d3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acetylcysteine - metabolism</topic><topic>Acetylcysteine - pharmacology</topic><topic>Atherosclerosis</topic><topic>Biological and medical sciences</topic><topic>Free Radical Scavengers - metabolism</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>LDL</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Medical sciences</topic><topic>Oxidation</topic><topic>Oxidation-Reduction</topic><topic>Pharmacology. Drug treatments</topic><topic>Respiratory system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rattan, Anil K.</creatorcontrib><creatorcontrib>Arad, Yadon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rattan, Anil K.</au><au>Arad, Yadon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1998-06-01</date><risdate>1998</risdate><volume>138</volume><issue>2</issue><spage>319</spage><epage>327</epage><pages>319-327</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>We investigated the ability of NAC to inhibit in vitro LDL oxidation, and the effects of the timing of NAC addition, repeated additions of NAC, and the presence of preoxidized LDL, on the oxidation reaction. NAC inhibited in vitro LDL oxidation induced by copper sulfate, 2,2′-azobis(2-amidinopropane) dihydrochloride, and UV light, and protected LDL against depletion of antioxidant vitamins. Glutathione was similarly effective against copper-mediated LDL oxidation. NAC's effectiveness was inversely related to the timing of its addition. Sequential NAC additions prolonged the lag phase more effectively than initial addition of the same total dose. NAC reduced CD formation during the oxidation of native LDL by oxidized LDL. NAC's effectiveness as an inhibitor of in vitro LDL oxidation is dependent on the temporal sequence of the oxidation reaction, sequential additions, and the presence of previously oxidized LDL.</abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>9690915</pmid><doi>10.1016/S0021-9150(98)00041-0</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 1998-06, Vol.138 (2), p.319-327
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_80048554
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcysteine - metabolism
Acetylcysteine - pharmacology
Atherosclerosis
Biological and medical sciences
Free Radical Scavengers - metabolism
Free Radical Scavengers - pharmacology
Humans
Kinetics
LDL
Lipid Peroxidation - drug effects
Lipoproteins, LDL - metabolism
Medical sciences
Oxidation
Oxidation-Reduction
Pharmacology. Drug treatments
Respiratory system
title Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A24%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20and%20kinetic%20determinants%20of%20the%20inhibition%20of%20LDL%20oxidation%20by%20N-acetylcysteine%20(NAC)&rft.jtitle=Atherosclerosis&rft.au=Rattan,%20Anil%20K.&rft.date=1998-06-01&rft.volume=138&rft.issue=2&rft.spage=319&rft.epage=327&rft.pages=319-327&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/S0021-9150(98)00041-0&rft_dat=%3Cproquest_cross%3E80048554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80048554&rft_id=info:pmid/9690915&rft_els_id=S0021915098000410&rfr_iscdi=true